Particularly, studies to see the association between PON1 activity and the stage of NAFLD or longitudinal cohort and intervention studies with the PON1 measurements will be required in patients with NAFLD. This evidence concerns the gene PON1 and metabolic dysfunction-associated steatotic liver disease.